CRYSVITA BURUSOMAB 20 MG FAM CAJ/1

Name: CRYSVITA

Category: ONCOLOGY

Active ingredient: BURUSOMAB

Description: Monoclonal Antibody Mechanism: Recombinant human monoclonal antibody (IgG1) that binds to fibroblast growth factor 23 (FGF23) and inhibits its activity. By inhibiting FGF23, burosumab increases renal tubular reabsorption of phosphate and increases the serum concentration of 1,25 dihydroxyvitamin D. USE: Treatment of X-linked hypophosphatemia

Weight: 20 MG

Presentation: 1 BOTTLE 1 ML

Recipe: YES

Cold Network: YES

Temperature: REFRIGERATED: 2°-8° C

Health Registry: NA

Important Notice

The information provided by Farmacias Hernandez Santé is for informational and educational purposes only.

Remember:

• This content is not a substitute for professional medical diagnosis, treatment, or prescription.
• Always consult your specialist before starting, modifying, or discontinuing any treatment.
• The proper use of medications should be supervised by a health professional.

Your well-being is our priority.